In cholangiocarcinoma, inhibiting miR-24 increases menin expression, increases fibrosis, decreases pro-angiogenic gene expression, and decreases tumor xenograft growth [231], consistent with its role as a negative regulator of menin. This evidence concerns the gene MEN1 and cholangiocarcinoma.